To study the temporal relationship between serum antibody response and human
papillomavirus type 16 (HPV-16) infection, a cohort of 325 university women were …

The relationship between human papillomavirus (HPV) DNA in the genital mucosa and
serum IgG to HPV-16,-18, and-6 was studied in a cohort of 588 college women. Among …

An ELISA to detect serum IgG antibody response to human papillomavirus (HPV) type 16
viruslike particles (VLPs) was evaluated in a case-control study of cervical neoplasia, nested …

Background Infection with human papillomavirus (HPV) 16 or HPV18 elicits an antibody
response, but whether the elicited antibodies protect women against subsequent infection …

The stability over time of serum IgG antibody levels to human papillomavirus type 16 (HPV-
16) was determined by comparing the HPV-16 capsid antibody levels in serial serum …

A human papillomavirus type 16 (HPV-16) virus-like particle (VLP)-based enzyme-linked
immunosorbent assay (ELISA) was used to measure serum antibody to capsid proteins in …

Background Previous studies have demonstrated that genital infection with high-risk types of
human papillomavirus (HPV), most often HPV16, is the most significant risk factor for the …

Infection with human papillomavirus (HPV) type 16 accounts for about half of cervical
cancers worldwide. This study investigated the seroepidemiology of HPV-16 infection in the …

Immunization with a vaccine of human papillomavirus (HPV) type 16 virus-like particles
(VLPs) can reduce incidence of HPV-16 infection and its related cervical intraepithelial …

A human papillomavirus (HPV) type 16 virus-like particle-based ELISA was used to assess
antivirion immune responses in 300 women participating in cervical cancer case-control …